SEC Form 4 · accession 0001209191-16-110194
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Marshall
Officer — SVP, Technical Operations
Period of report
Mar 21, 2016
Accepted (ET)
Mar 23, 2016 · 3:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2016 | M | 1,100 | $9.05 | A | 2,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $9.05 | Mar 21, 2016 | M | 1,100 | D | — | Dec 12, 2024 | Common Stock | 1,100 | 42,800 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.